Cargando…

Gelsolin activity controls efficient early HIV-1 infection

BACKGROUND: HIV-1 entry into target lymphocytes requires the activity of actin adaptors that stabilize and reorganize cortical F-actin, like moesin and filamin-A. These alterations are necessary for the redistribution of CD4-CXCR4/CCR5 to one pole of the cell, a process that increases the probabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Expósito, Laura, Ziglio, Serena, Barroso-González, Jonathan, de Armas-Rillo, Laura, Valera, María-Soledad, Zipeto, Donato, Machado, José-David, Valenzuela-Fernández, Agustín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626799/
https://www.ncbi.nlm.nih.gov/pubmed/23575248
http://dx.doi.org/10.1186/1742-4690-10-39
_version_ 1782266250025500672
author García-Expósito, Laura
Ziglio, Serena
Barroso-González, Jonathan
de Armas-Rillo, Laura
Valera, María-Soledad
Zipeto, Donato
Machado, José-David
Valenzuela-Fernández, Agustín
author_facet García-Expósito, Laura
Ziglio, Serena
Barroso-González, Jonathan
de Armas-Rillo, Laura
Valera, María-Soledad
Zipeto, Donato
Machado, José-David
Valenzuela-Fernández, Agustín
author_sort García-Expósito, Laura
collection PubMed
description BACKGROUND: HIV-1 entry into target lymphocytes requires the activity of actin adaptors that stabilize and reorganize cortical F-actin, like moesin and filamin-A. These alterations are necessary for the redistribution of CD4-CXCR4/CCR5 to one pole of the cell, a process that increases the probability of HIV-1 Envelope (Env)-CD4/co-receptor interactions and that generates the tension at the plasma membrane necessary to potentiate fusion pore formation, thereby favouring early HIV-1 infection. However, it remains unclear whether the dynamic processing of F-actin and the amount of cortical actin available during the initial virus-cell contact are required to such events. RESULTS: Here we show that gelsolin restructures cortical F-actin during HIV-1 Env-gp120-mediated signalling, without affecting cell-surface expression of receptors or viral co-receptor signalling. Remarkably, efficient HIV-1 Env-mediated membrane fusion and infection of permissive lymphocytes were impaired when gelsolin was either overexpressed or silenced, which led to a loss or gain of cortical actin, respectively. Indeed, HIV-1 Env-gp120-induced F-actin reorganization and viral receptor capping were impaired under these experimental conditions. Moreover, gelsolin knockdown promoted HIV-1 Env-gp120-mediated aberrant pseudopodia formation. These perturbed-actin events are responsible for the inhibition of early HIV-1 infection. CONCLUSIONS: For the first time we provide evidence that through its severing of cortical actin, and by controlling the amount of actin available for reorganization during HIV-1 Env-mediated viral fusion, entry and infection, gelsolin can constitute a barrier that restricts HIV-1 infection of CD4+ lymphocytes in a pre-fusion step. These findings provide important insights into the complex molecular and actin-associated dynamics events that underlie early viral infection. Thus, we propose that gelsolin is a new factor that can limit HIV-1 infection acting at a pre-fusion step, and accordingly, cell-signals that regulate gelsolin expression and/or its actin-severing activity may be crucial to combat HIV-1 infection.
format Online
Article
Text
id pubmed-3626799
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36267992013-04-16 Gelsolin activity controls efficient early HIV-1 infection García-Expósito, Laura Ziglio, Serena Barroso-González, Jonathan de Armas-Rillo, Laura Valera, María-Soledad Zipeto, Donato Machado, José-David Valenzuela-Fernández, Agustín Retrovirology Research BACKGROUND: HIV-1 entry into target lymphocytes requires the activity of actin adaptors that stabilize and reorganize cortical F-actin, like moesin and filamin-A. These alterations are necessary for the redistribution of CD4-CXCR4/CCR5 to one pole of the cell, a process that increases the probability of HIV-1 Envelope (Env)-CD4/co-receptor interactions and that generates the tension at the plasma membrane necessary to potentiate fusion pore formation, thereby favouring early HIV-1 infection. However, it remains unclear whether the dynamic processing of F-actin and the amount of cortical actin available during the initial virus-cell contact are required to such events. RESULTS: Here we show that gelsolin restructures cortical F-actin during HIV-1 Env-gp120-mediated signalling, without affecting cell-surface expression of receptors or viral co-receptor signalling. Remarkably, efficient HIV-1 Env-mediated membrane fusion and infection of permissive lymphocytes were impaired when gelsolin was either overexpressed or silenced, which led to a loss or gain of cortical actin, respectively. Indeed, HIV-1 Env-gp120-induced F-actin reorganization and viral receptor capping were impaired under these experimental conditions. Moreover, gelsolin knockdown promoted HIV-1 Env-gp120-mediated aberrant pseudopodia formation. These perturbed-actin events are responsible for the inhibition of early HIV-1 infection. CONCLUSIONS: For the first time we provide evidence that through its severing of cortical actin, and by controlling the amount of actin available for reorganization during HIV-1 Env-mediated viral fusion, entry and infection, gelsolin can constitute a barrier that restricts HIV-1 infection of CD4+ lymphocytes in a pre-fusion step. These findings provide important insights into the complex molecular and actin-associated dynamics events that underlie early viral infection. Thus, we propose that gelsolin is a new factor that can limit HIV-1 infection acting at a pre-fusion step, and accordingly, cell-signals that regulate gelsolin expression and/or its actin-severing activity may be crucial to combat HIV-1 infection. BioMed Central 2013-04-10 /pmc/articles/PMC3626799/ /pubmed/23575248 http://dx.doi.org/10.1186/1742-4690-10-39 Text en Copyright © 2013 García-Expósito et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
García-Expósito, Laura
Ziglio, Serena
Barroso-González, Jonathan
de Armas-Rillo, Laura
Valera, María-Soledad
Zipeto, Donato
Machado, José-David
Valenzuela-Fernández, Agustín
Gelsolin activity controls efficient early HIV-1 infection
title Gelsolin activity controls efficient early HIV-1 infection
title_full Gelsolin activity controls efficient early HIV-1 infection
title_fullStr Gelsolin activity controls efficient early HIV-1 infection
title_full_unstemmed Gelsolin activity controls efficient early HIV-1 infection
title_short Gelsolin activity controls efficient early HIV-1 infection
title_sort gelsolin activity controls efficient early hiv-1 infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626799/
https://www.ncbi.nlm.nih.gov/pubmed/23575248
http://dx.doi.org/10.1186/1742-4690-10-39
work_keys_str_mv AT garciaexpositolaura gelsolinactivitycontrolsefficientearlyhiv1infection
AT ziglioserena gelsolinactivitycontrolsefficientearlyhiv1infection
AT barrosogonzalezjonathan gelsolinactivitycontrolsefficientearlyhiv1infection
AT dearmasrillolaura gelsolinactivitycontrolsefficientearlyhiv1infection
AT valeramariasoledad gelsolinactivitycontrolsefficientearlyhiv1infection
AT zipetodonato gelsolinactivitycontrolsefficientearlyhiv1infection
AT machadojosedavid gelsolinactivitycontrolsefficientearlyhiv1infection
AT valenzuelafernandezagustin gelsolinactivitycontrolsefficientearlyhiv1infection